‘We’ve always been an acquisitions company’: Ebos CEO on firm's future

‘We’ve always been an acquisitions company’: Ebos CEO on firm's future
Ebos CEO John Cullity is looking to other areas after losing the Chemist Warehouse contract. (Image: NZME)
Ella Somers
Ebos is looking to expand as it faces up to life without its $2 billion Chemist Warehouse contract.Although Ebos’ chief executive says the healthcare wholesaler doesn’t give forecasts, there’s one thing he’s certain will remain constant: Ebos will continue to be an acquisitions company.“That's been in the company's DNA even before I joined,” John Cullity told BusinessDesk on Wednesday after the company’s full-year results were released.Cullity has been Ebos’ CEO since 2018 and before...

More Markets

NZ sharemaket up 0.1% despite 'volatile' markets
Markets Market Close

NZ sharemaket up 0.1% despite 'volatile' markets

The S&P/NZX 50 Index closed at 12,338.57, up 18.38 points or 0.15%.

NZX-listed companies take stock in wake of US tariff moves
Economy

NZX-listed companies take stock in wake of US tariff moves

Wine makers, manufacturers and others mull what trade wars will bring.

Analysts struggle to find upside from Trump tariffs
Economy

Analysts struggle to find upside from Trump tariffs

‘They've forgotten the lessons of the Great Depression,’ one analyst said.